Cell Signaling Technology, Inc. Acquires BIOKE and Expands Operations to Europe

DANVERS, Mass.--(BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST), a leading manufacturer and distributor of antibodies and related reagent products for biomedical research, announced today that it has acquired all the shares of BIOKÉ, B.V., the company’s current distributor of its research products in the Benelux region. BIOKÉ B.V., established in the Netherlands, has been renamed Cell Signaling Technology Europe, B.V. and will become CST’s base of operations in Europe. CST Europe is a wholly owned subsidiary of CST, Inc. and will begin fulfilling orders for Europe effective January 1st, 2010.

Back to news